Robert Holmlin
Chief Executive Officer at BIONANO GENOMICS, INC.
Net worth: 86 763 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shana Kelley | M | - |
Xagenic, Inc.
 Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | 14 years |
| Andrew Hobson | M | 62 |
Innovatus Life Sciences Acquisition Corp.
 Innovatus Life Sciences Acquisition Corp. Financial ConglomeratesFinance Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 8, 2021 and is headquartered in New York, NY. | 3 years |
| David Barker | M | 82 | 14 years | |
| Hannah Mamuszka | F | 47 | 4 years | |
| Yvonne Linney | M | 62 | 4 years | |
| Aleksandar Rajkovic | M | - | 2 years | |
| Vincent J. Wong | M | - | 3 years | |
| Christopher Twomey | M | 64 | 6 years | |
| David Schiff | M | 51 |
Innovatus Life Sciences Acquisition Corp.
Innovatus Life Sciences Acquisition Corp. Financial ConglomeratesFinance Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 8, 2021 and is headquartered in New York, NY. | 3 years |
| Kristiina Vuori | M | 56 | 5 years | |
| Albert Luderer | M | 75 | 13 years | |
| Marin Stanislas | M | - | - | |
| Hastie Alex | M | - | - | |
| Gülsen Kama | F | 51 | 1 years | |
| Helene Klein | F | - | 2 years | |
| Gus Likogiannis | M | - |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Dustin Dickens | M | - |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Jonathan Dixon | M | - | 1 years | |
| Mark Oldakowski | M | 50 | 10 years | |
| Claes Ekstrom | M | 53 |
Innovatus Life Sciences Acquisition Corp.
Innovatus Life Sciences Acquisition Corp. Financial ConglomeratesFinance Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 8, 2021 and is headquartered in New York, NY. | 3 years |
| Alka Chaubey | M | 51 | 4 years | |
| Mark Adamchak | M | - | - | |
| Jesse I. Treu | M | 76 |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Luis Diaz | M | 53 |
Innovatus Life Sciences Acquisition Corp.
Innovatus Life Sciences Acquisition Corp. Financial ConglomeratesFinance Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 8, 2021 and is headquartered in New York, NY. | - |
| Shermaine Tilley | M | 72 |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | 12 years |
| Dion Madsen | M | 56 |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Geoff Duyk | M | 64 |
Innovatus Life Sciences Acquisition Corp.
Innovatus Life Sciences Acquisition Corp. Financial ConglomeratesFinance Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on January 8, 2021 and is headquartered in New York, NY. | - |
| Shroff Hema | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael James Ward | M | 52 | 5 years | |
| Mark Borodkin | M | 50 | - | |
| Daqing Cai | M | 59 | 5 years | |
| Edward L. Erickson | M | 76 | - | |
| Quan Zhou | M | 49 | 1 years | |
| Jun Feng Wang | M | 50 | 2 years | |
| Gloria Lee | M | - |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Christopher Stewart | M | 54 | 3 years | |
| Han Cao | M | 55 | 15 years | |
| Tracy S. Warren | F | - | - | |
| Jason Priar | M | - | 1 years | |
| Richard Shippy | M | - | 1 years | |
| Terry Salyer | F | - | - | |
| Tom Glawdel | M | 40 |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | 2 years |
| Amanda Hernandez | F | - | 1 years | |
| Da Qing Cai | M | 59 | 1 years | |
| Stephanie Hoyle | F | - | 1 years | |
| Heather Adams | F | - | - | |
| Joel R. Jung | M | 66 | 2 years | |
| Tom Waddell | M | - |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Christopher Jerger | M | - |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Warren Robinson | M | 55 | 3 years | |
| Fahim Amini | M | - | - | |
| Graham D. Jack | M | - |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | 5 years |
| Edward Jonasson | M | 55 |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | 4 years |
| Michael S. Paul | M | - | - | |
| Linda McAllister | M | - |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Konrad Faulstich | M | - |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Randall W. Wilhoite | M | 58 |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Bruce A. Cohen | M | 71 |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | - |
| Alex Helm | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 43 | 72.88% |
| Canada | 16 | 27.12% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Holmlin
- Personal Network
